Cytodyn Inc (CYDY)

[HyGro]

"Company's retention of investor relations consultants"

From the Company's 10Q SEC filing 1/10/22:

"The Company has received subpoenas from the United States Securities and Exchange Commission (“SEC”) and the United States Department of Justice (“DOJ”) requesting documents and information concerning, among other matters, leronlimab, the Company’s public statements regarding the use of leronlimab as a potential treatment for COVID-19, HIV, and triple-negative breast cancer, related communications with the FDA, investors, and others, litigation involving former employees, the Company’s retention of investor relations consultants..."


https://www.cytodyn.com/investors/sec-filings/all-sec-filings/content/0001558370-22-000190/0001558370-22-000190.pdf